Incyte
INCY
#1191
Rank
NZ$33.69 B
Marketcap
NZ$169.30
Share price
0.20%
Change (1 day)
31.00%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$67.7 Million

According to Incyte's latest financial reports the company's total debt is NZ$67.7 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$69.77 M-9.62%
2024-12-31NZ$77.2 M27.53%
2023-12-31NZ$60.54 M-7.28%
2022-12-31NZ$65.29 M-0.49%
2021-12-31NZ$65.61 M-0.39%
2020-12-31NZ$65.87 M-26.33%
2019-12-31NZ$89.42 M66.02%
2018-12-31NZ$53.86 M59.38%
2017-12-31NZ$33.79 M-96.41%
2016-12-31NZ$0.94 B3.84%
2015-12-31NZ$0.90 B5.11%
2014-12-31NZ$0.86 B7.04%
2013-12-31NZ$0.80 B100.04%
2012-12-31NZ$0.40 B-0.65%
2011-12-31NZ$0.40 B6.5%
2010-12-31NZ$0.38 B-37.66%
2009-12-31NZ$0.61 B-10.63%
2008-12-31NZ$0.68 B35.28%
2007-12-31NZ$0.50 B-4.2%
2006-12-31NZ$0.52 B5.32%
2005-12-31NZ$0.50 B-5.77%
2004-12-31NZ$0.53 B105.65%
2003-12-31NZ$0.25 B-21.48%
2002-12-31NZ$0.32 B-23.85%
2001-12-31NZ$0.43 B1.85%
2000-12-31NZ$0.42 B110642.63%
1999-12-31NZ$0.38 M-74.79%
1998-12-31NZ$1.51 M
1996-12-31NZ$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
NZ$59.26 B 87,438.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$101.94 B 150,469.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$71.20 B 105,074.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$91.45 B 134,976.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.75 B 1,016.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.20 B 201.68%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$81.91 M 20.99%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ$64.8 M-4.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.34 B 413.74%๐Ÿ‡บ๐Ÿ‡ธ USA